CD8A and cervical squamous intraepithelial neoplasia: Inclusion of GPI-0100 also enhanced the E7-specific CD8 T cell response to TA-CIN vaccination and protected mice from challenge with the TC-1 cell line, an HPV16 E6/E7+ murine tumor model [16].